None
Quote | Jounce Therapeutics Inc. (NASDAQ:JNCE)
Last: | $1.88 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $1.88 |
High: | $0 |
Low: | $0 |
Volume: | 169,314 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Jounce Therapeutics Inc. (NASDAQ:JNCE)
CAMBRIDGE, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE) (“Jounce” or the “Company”), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Co...
2023-04-18 16:26:35 ET Summary Jounce Therapeutics, Inc. is being acquired by Concentra, a subsidiary of Tang Capital Partners, at $1.85 per share in cash, plus a non-tradeable CVR. Concentra's offer was deemed better than a merger with Redx Pharma or liquidation overseen by curre...
Message Board Posts | Jounce Therapeutics Inc. (NASDAQ:JNCE)
Subject | By | Source | When |
---|---|---|---|
Amended Schedule 14D-9 (4/24/23) | Enterprising Investor | investorshub | 04/25/2023 9:10:56 AM |
Jounce Acquisition: Exploring Whether It Is Worth It | Enterprising Investor | investorshub | 04/25/2023 9:05:45 AM |
Jounce Therapeutics Enters Into Agreement to Be Acquired | Enterprising Investor | investorshub | 04/25/2023 9:03:24 AM |
znewcar1: $JNCE 40% v28,9M c1.49 f52,140M H1.64 ML.9 LL.58 | znewcar1 | investorshangout | 03/15/2023 8:10:02 PM |
I know nothing about this Company. The news | subslover | investorshub | 03/15/2023 2:31:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Jounce Therapeutics Inc. Company Name:
JNCE Stock Symbol:
NASDAQ Market:
Jounce Therapeutics Inc. Website:
CAMBRIDGE, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE) (“Jounce” or the “Company”), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Co...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. CAMBRIDGE, Mass., April 03, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. ("Jounce" or t...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE)...